Uptravi generic availability?

Short answer: No. There isn’t a generic version of Uptravi (selexipag) available in the U.S. or EU right now.

Why: Generic versions typically come only after patent protections and any regulatory exclusivity expire. Selexipag is still covered by Janssen patents and related protections in many regions, so no approved generic has entered the market yet.

If you want to check current status yourself:
- U.S. patent/status: FDA Orange Book and USPTO Patent Center
- European status: European Patent Office databases or EMA communications
- For other countries: local patent databases and national drug registries

If cost or access is the concern, you could ask your clinician about alternatives in the PAH treatment toolbox and consider Janssen’s patient assistance programs or insurance options. If you’d like, I can help look up the latest patent or regulatory status for a specific country.